Dr. Katz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
126 E Lincoln Ave
Ry 34-A252
Rahway, NJ 07065Phone+1 732-594-6957
Education & Training
University of California, Davis, School of MedicineClass of 2000
Certifications & Licensure
NJ State Medical License 2009 - 2019
CA State Medical License 2002 - 2018
Publications & Presentations
PubMed
- 36 citationsAMG 151 (ARRY‐403), a novel glucokinase activator, decreases fasting and postprandial glycaemia in patients with type 2 diabetesLeonid Katz, Nick Manamley, Wendy Snyder, Michael G. Dodds, Nataliya Agafonova
Diabetes, Obesity & Metabolism. 2016-02-01 - 30 citationsThe development of denosumab for the treatment of diseases of bone loss and cancer-induced bone destructionCarsten Goessl, Leonid Katz, William C. Dougall, Paul J. Kostenuik, Holly Brenza Zoog
Annals of the New York Academy of Sciences. 2012-08-01 - 18 citationsDesign and methods of a postmarketing pharmacoepidemiology study assessing long-term safety of Prolia ® (denosumab) for the treatment of postmenopausal osteoporosis ‡Fei Xue, Haijun Ma, Catherine Stehman-Breen, Christine A. Haller, Leonid Katz
Pharmacoepidemiology and Drug Safety. 2013-10-01
Other Languages
- Russian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
